An emerging class of anticancer drugs called EZH2 inhibitors may greatly enhance the potency of some cancer immunotherapies, according to a preclinical study led by Weill Cornell Medicine lymphoma researchers. Dec 5, 2024 0 7 Psychology & Psychiatry ...
spearheading novel restoration treatments and creating imaginative clinical projects and facilities. Based at Burke Rehabilitation Hospital and working synergistically with its scholarly member Weill Cornell Medicine, BMRI is contained few neurological malady, damage and utilitarian recuperation centered research ...